Nehmen Sie Kontakt auf.

Zur Kontaktliste

Haben Sie Fragen zu Services oder zum Literaturangebot von ZB MED? Benötigen Sie Tipps zur Recherche in LIVIVO?

Kontakt

info@zbmed.de
Telefonnummer: +49 (0)221 478-5685

Köln

Medizin und Gesundheitswesen

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Gleueler Straße 60
50931 Köln

Bonn

Ernährungs-, Umwelt- und Agrarwissenschaften

Adresse:
ZB MED – Informationszentrum Lebenswissenschaften
Friedrich-Hirzebruch-Allee 4
53115 Bonn

InfoCenter

INFORMATION.

WISSEN.
LEBEN.

Infrastruktur- und Forschungszentrum für lebenswissenschaftliche Daten und Informationen.

Thema Lebenswissenschaften?

Wir haben die Werkzeuge für Ihre passgenauen Recherchen.

Kongressdetails

19.03.2024 - 21.03.2024

The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities

Veranstaltungsort
Bergamo
Kontakt und Ansprechparter

Hannah Barrs <hannah.barrs@eacr.org>

Land
Italien
Kurzinfo

This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy.


Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.



The target audience for this conference is: scientists, postdocs, and graduate students interested in multiple aspects of cancer biology, immunology, and therapeutics; industry scientists interested in translational research and novel therapeutic approaches; and journal editors interested in cutting-edge cancer biology.